RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities.
The last earnings update was 86 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
RavenQuest BioMed. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
RavenQuest BioMed's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RavenQuest BioMed has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Professional Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare RavenQuest BioMed's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare RavenQuest BioMed's earnings growth to the Canada market average as no estimate data is available.
Unable to compare RavenQuest BioMed's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if RavenQuest BioMed is high growth as no earnings estimate data is available.
Unable to determine if RavenQuest BioMed is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
RavenQuest BioMed's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
RavenQuest BioMed's finances.
The net worth of a company is the difference between its assets and liabilities.
RavenQuest BioMed's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
RavenQuest BioMed's long term commitments exceed its cash and other short term assets.
This treemap shows a more detailed breakdown of
RavenQuest BioMed's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
Debt is not covered by short term assets, assets are 0.2x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
What Investors Should Know About Ravenquest Biomed Inc.'s (CNSX:RQB) Financial Strength
(CNSX:RQB) is a small-cap stock with a market capitalization of CA$70m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Assessing first and foremost the financial health is
What Kind Of Shareholder Owns Most Ravenquest Biomed Inc. (CNSX:RQB) Stock?
A look at the shareholders of Ravenquest Biomed Inc. … As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.'. … With a market capitalization of CA$73m, Ravenquest Biomed is a small cap stock, so it might not be well known by many institutional investors.
How Many Insiders Sold Ravenquest Biomed Inc (CNSX:RQB) Shares?
So shareholders might well want to know whether insiders have been buying or selling shares in Ravenquest Biomed Inc (CNSX:RQB). … Ravenquest Biomed Insider Transactions Over The Last Year. … Christopher Bechtel was the only individual insider to sell shares in the last twelve months
How Financially Strong Is Ravenquest Biomed Inc (CNSX:RQB)?
Ravenquest Biomed Inc (CNSX:RQB) is a small-cap stock with a market capitalization of CA$99m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Assessing first and foremost the financial health is
Ravenquest Biomed Inc (CNSX:RQB): When Will It Breakeven?
Ravenquest Biomed Inc's (CNSX:RQB):. … Ravenquest Biomed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. … The CA$66.7m market-cap posted a loss in its most recent financial year of -CA$3.3m and a latest trailing-twelve-month loss of -CA$7.7m leading to an even wider gap between loss and breakeven?
Is Ravenquest Biomed Inc (CNSX:RQB) A Financially Sound Company?
Investors are always looking for growth in small-cap stocks like Ravenquest Biomed Inc (CNSX:RQB), with a market cap of CA$75.07m. … However, an important fact which most ignore is: how financially healthy is the business?
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.